CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on October 15, 2009
Clinical Journal of the American Society of Nephrology
© 2009 American Society of Nephrology
doi: 10.2215/CJN.04320709
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Nakamura, S.
Right arrow Articles by Kawano, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, S.
Right arrow Articles by Kawano, Y.

Coronary Calcification in Patients with Chronic Kidney Disease and Coronary Artery Disease

Satoko Nakamura, Hatsue Ishibashi-Ueda, Sinichiro Niizuma, Fumiki Yoshihara, Takeshi Horio, and Yuhei Kawano

Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, Department of Pathology, National Cardiovascular Center, Osaka, Japan

Correspondence: Dr. Satoko Nakamura, Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan. Phone: +81-6-6833-5012; Fax: +81-6-6872-7486; E-mail: snakamur{at}hsp.ncvc.go.jp

Background and objectives: A close linkage between chronic kidney disease (CKD) and cardiovascular disease (CVD) has been demonstrated. Coronary artery calcification (CAC) is considered to be the causal link connecting them. The aim of the study is to determine the relationship between level of kidney function and the prevalence of CAC.

Design, setting, participants, & measurements: Autopsy subjects known to have coronary artery disease and a wide range of kidney function were studied. Patients without CKD were classified into five groups depending on estimated GFR (eGFR) and proteinuria: eGFR ≥60 ml/min/1.73 m2 without proteinuria; CKD1/2: eGFR ≥60 ml/min/1.73 m2 with proteinuria; CKD3: 60 ml/min/1.73 m2 >eGFR ≥30 ml/min/1.73 m2; CKD4/5: eGFR <30 ml/min/1.73 m2; and CKD5D: on hemodialysis. Intimal and medial calcification of the coronary arteries was evaluated. Risk factors for CVD and uremia were identified as relevant to CAC using logistic regression analysis.

Results: Intimal calcification of plaques was present in all groups, but was most frequent and severe in the CKD5D group and less so in the CKD4/5 and CKD3 groups. Risk factors included luminal stenosis, age, smoking, diabetes, calcium-phosphorus product, inflammation, and kidney function. Medial calcification was seen in a small number of CKD4/5 and CKD5D groups. Risk factors were use of calcium-containing phosphate binders, hemodialysis treatment, and duration.

Conclusions: It was concluded that CAC was present in the intimal plaque of both nonrenal and renal patients. Renal function and traditional risks were linked to initimal calcification. Medial calcification occurred only in CKD patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Society of Nephrology.